Blue Owl Capital Holdings »

Nvni Group shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Nvni Group (NVNIW) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Nvni Group

Tip: Access up to 7 years of quarterly data

All positions including Nvni Group held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nvni Group by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.0k 200k 0.02

More positions owned by Blue Owl Capital Holdings

Nuveen Churchill Direct Lend Com Shs (NCDL)
Klaviyo Com Ser A (KVYO)
Tourmaline Bio (TRML)
Pliant Therapeutics (PLRX)
Cullinan Oncology (CGEM)
Owl Rock Capital Corporation (OBDC)
Larimar Therapeutics (LRMR)
Proshares Tr Ultrapro Qqq (TQQQ)
Engene Holdings (ENGN)
Evercommerce (EVCM)
Acelyrin (SLRN)
Conduent Incorporate (CNDT)
Repare Therapeutics Ord (RPTX)
Context Therapeutics (CNTX)
Ultragenyx Pharmaceutical (RARE)

View all positions for Blue Owl Capital Holdings

Top funds holding Nvni Group

Highbridge Capital Management
Cowen And Company
Aristeia Capital
Farallon Capital Management
OZ Management
D. E. Shaw & Co
Periscope Capital
Tenor Capital Management
Saba Capital Management
Clear Street Derivatives
Blue Owl Capital Holdings
Atalaya Capital Management
Polar Securities
Whitebox Advisors
Q Global Advisors

View all funds holding Nvni Group